HONG KONG SAR – EQS Newswire – 31 August 2026 – A national charging framework for surgical robots was formally established earlier this year, heralding imminent industry-wide volume growth. With payment rules clarified, billing barriers for hospitals procuring such equipment have been removed, opening a window for accelerated installation of domestic surgical robots.
On 28 August, TrueHealth Medical (02697.HK, the "Company") released its maiden interim results. During the reporting period, the Company booked revenue of RMB 5.671 million, jumping nearly 32 times year-on-year. Gross profit reached RMB 4.363 million, soaring more than 36 times year-on-year, with an overall gross margin of 76.9%, representing an uplift of 9.8 percentage points against the prior-year period. Revenue from surgical robot products stood at RMB 5.16 million, accounting for 91.0% of total revenue, marking the commencement of revenue recognition.
Consumables business grew in tandem, delivering consumables sales of RMB 408,000 during the period, up 135.8% year-on-year. As device installations scale up, profitability from repeat orders has improved, with gross margin rising from 67.1% in the same period last year to 79.9%. Sales coverage has also expanded, shifting from a Beijing-only footprint last year to multiple regions including North and South China. North China emerged as the core delivery market in the period, contributing 57.7% of sales, while South China accounted for 35.8%. Driven by rising device installations, repeat purchases of consumables and geographic expansion, the Company's overall business has entered a sustainable growth trajectory.
The Company stated in its announcement that the "device plus consumables" business model has been validated by its first batch of post-listing operational data. It will maintain its existing pace for pipeline advancement and ecosystem buildout in H2, retaining confidence in sustained commercial expansion.
TrueHealth Medical specializes in percutaneous puncture surgical robots and has completed the full commercialization cycle from technology development to market validation. All four models of its core products have obtained Class III medical device registration certificates from the National Medical Products Administration (NMPA), giving the Company the largest number of approved models among Chinese peers and a comprehensive product portfolio. Its installed base spans nearly 100 medical institutions across major regions, ranking among the industry leaders. The sales system built on distributor networks, benchmark hospitals and clinical training support is fully in place.
While the commercial foundation solidifies, the Company has ramped up R&D investment. R&D expenditure totaled RMB 26.931 million in the reporting period, rising 15.2% year-on-year. Investment focuses on two key areas: expansion of clinical indications and overseas registration.
On clinical indication expansion: R&D spending on core products increased from RMB 7.4 million in the prior-year period to RMB 10.7 million. The pulmonary indication of TH-X MW, the world's first and only microwave ablation surgical robot integrating precision localization and microwave ablation, received NMPA approval within the reporting period. With this milestone, this globally-first percutaneous microwave ablation surgical robot now covers both liver and lung tumor treatment scenarios. The registration clinical trial for the flagship TH-S1 puncture surgical robot, expanded for retroperitoneal lesions, has enrolled 16 patients. The Company plans to file the registration application in Q4 2026, with NMPA approval anticipated in H2 2027. For overseas registration: CE certification applications for core products were submitted and accepted in January 2026, with certification expected in Q4 2026. Upon obtaining CE certification, the percutaneous puncture surgical robots will be able to enter the EU market, extending the Company's footprint beyond China.
Additionally, the Company's forward-looking long-term pipeline, including the organ normothermic perfusion system, follows a clear timeline. The system recently won the bid for the research equipment procurement project of the Yunnan Key Laboratory of Gene-edited Miniature Pigs and Xenotransplantation at Yunnan Agricultural University. This milestone confirms completion of engineering finalization and prototype verification, laying the technical foundation to move from research settings to preclinical studies and eventual clinical adoption. It marks a pivotal transition of TrueHealth Medical's organ normothermic perfusion system from R&D to industrialization. This cutting-edge technology aligns closely with the 15th Five-Year Plan strategic roadmap in China, which identifies organ manufacturing, life support devices and advanced biotechnologies as prioritized research areas.
Beyond scaling commercial sales, the Company continues to build strategic depth across channels, products and technologies. Three landmark initiatives were finalized in August: a strategic cooperation agreement with Genertec Liaoning Pharmaceuticals to systematically deliver minimally invasive diagnosis and treatment solutions to regional markets via this state-owned enterprise platform, unlocking large-scale hospital adoption; the organ normothermic perfusion system winning the Yunnan Agricultural University tender, bringing the second growth curve into market validation; and a collaboration with the Tianjin Embodied Intelligence Innovation Center to build technical capabilities for surgical robots to evolve from "execution tools" into "intelligent agents", securing a leading edge for long-term technological advancement.
Policy tailwinds have materialized, and the Company's commercial flywheel is now gaining traction. In August, TrueHealth Medical was included in the Hang Seng Composite Index, qualifying it for Stock Connect inclusion. Its maiden interim results validate the robustness of its "device plus consumables" business model, laying a solid foundation for sustained commercial scaling ahead. Several key dimensions merit close attention: robust expansion in new installations, consistent growth in recurring consumables revenue, timely roll‑out of clinical indication expansions for pipelines including TH‑S1, overseas market penetration following CE certification, and validation of follow‑on orders for emerging businesses such as organ perfusion systems.
Hashtag: #TrueHealthMedical
The issuer is solely responsible for the content of this announcement.
About TrueHealth Medical Technology Development Co., Limited
A nationally accredited "Little Giant" enterprise (Specialized, Sophisticated, Distinctive & Innovative), Guangdong TrueHealth Medical Technology Development Co., Limited leverages artificial intelligence and robotic control technologies to develop and commercialize intelligent robots for soft tissue puncture diagnosis and organ repair. Its core offerings cover percutaneous puncture navigation and microwave ablation guided systems. The ZhenYiDa® percutaneous puncture navigation and positioning system holds NMPA China-first certification, while the ZhenYiDa® navigation and positioning microwave ablation system is accredited as a world-first innovation by NMPA. The Company undertakes key projects under China's 14th Five-Year National Key R&D Program, with its products featured in national flagship schemes including high-end medical device roll-out initiatives, AI medical device innovation program and the Catalog of Outstanding Domestic Medical Devices. TrueHealth Medical aims to deploy AI and surgical robotics to advance precision, minimally invasive therapeutic solutions for widespread clinical use.
** This press release is distributed by Media OutReach Newswire through automated distribution system, for which the client assumes full responsibility. **
Proposed an interim dividend of HK11.0 cents per share
Highlights:
- Revenue increased to approximately HK$1,450.9 million.
- Gross profit increased to approximately HK$518.8 million.
- Profit attributable to owners of the Company amounted to approximately HK$116.2 million.
- As at 30 June 2026, the Group operated a total of 190 chain retail stores
- Basic earnings per share was approximately HK11.6 cents. The Board recommended the payment of interim dividend of HK11.0 cents per share.
Financial Highlights:
| | For the 6 months ended 30 Jun |
| HK$'000 | 2026 | 2025 | Change |
| Revenue | 1,450,897 | 1,436,576 | +1.0% |
| Sales derived from private label products | 277,194 | 251,203 | +10.3% |
| Gross profit | 518,758 | 518,177 | +0.1% |
| Interim dividend per share (HK cents) | 11.0 | 11.0 | - |
HONG KONG SAR – Media OutReach Newswire – 31 August 2026 – Best Mart 360 Holdings Limited ("Best Mart 360" or the "Company", together with its subsidiaries, the "Group"; stock code: 2360.HK), a leading leisure food retailer in Hong Kong, announced its interim results for the six months ended 30 June 2026 ("the Period under Review"). During the Period under Review, the revenue recorded by the Group amounted to approximately HK$1,450,897,000, representing an increase of approximately 1.0% as compared to approximately HK$1,436,576,000 for the six months ended 30 June 2025 (the "Corresponding Period Last Year").
During the Period under Review, profit attributable to owners of the Company amounted to approximately HK$116,221,000.
For the six months ended 30 June 2026, gross profit of the Group was approximately HK$518,758,000, representing an increase of approximately 0.1%, as compared to gross profit of approximately HK$518,177,000. Gross profit margin during the period was approximately 35.8%. During the Period under Review, basic earnings per share of the Group was approximately HK11.6 cents. The Board recommended the payment of interim dividend of HK11.0 cents per share.
BUSINESS REVIEW
CHAIN RETAIL STORES
As at 30 June 2026, the Group operated a total of 190 chain retail stores, including 184 chain retail stores in Hong Kong and 6 chain retail stores in Macau, respectively. During the Period under Review, the Group continued to implement its store network optimization strategy to fully showcase its diverse product portfolio, further enhance its overall brand image and provide customers with a more comfortable shopping environment.
Since 2021, the Group has launched its brand of global wine and food stores "FoodVille", which provides mid-to-high-end, premium food products from around the globe. These include fine wines, premium chocolates, health foods, cheese, Western sauces and ingredients from around the world, aming to cater to the market's pursuit of a quality of life and expanding the Group's customer base. As at 30 June 2026, the Group operated a total of 8 retail stores under the brand.
During the Period under Review, the rental expenses (on a cash basis) of the Group's retail stores accounted for approximately 9.7% of its sales revenue.
THE PRODUCTS
During the Period under Review, the Group adhered to its global procurement strategy, sourcing high-quality products from around the world to provide customers with a diversified range of choices. During the Period under Review, the Group sold over 1,045 brands and more than 3,054 stock keeping units ("SKUs") of products in total. The Group continuously optimised its product portfolio and actively introduced a variety of new products and flavours to meet customers' ever-changing needs.
To enrich its product mix and maintain effective control over product quality, supply stability and profit margins, the Group continued to actively develop its private label products. During the Period under Review, sales derived from private label products amounted to approximately HK$277,194,000 (six months ended 30 June 2025: approximately HK$251,203,000), which accounted for approximately 19.1% of the Group's total revenue for the Period under Review. The Group had a total of 12 private labels covering approximately 272 SKUs of products, including masks, canned Chinese delicacies, cereals, milk, honey, nuts and dried fruits as well as a wide range of leisure food products.
MEMBERSHIP SCHEME AND MARKETING & PROMOTIONAL ACTIVITIES
As at 30 June 2026, the Group had a cumulative total of approximately 2,469,754 registered fans and members (30 June 2025: approximately 2,243,198). As at 30 June 2026, the number of mobile app members reached approximately 1,374,462 (30 June 2025: approximately 1,238,775).
During the Period under Review, the Group continued to carry out a variety of marketing activities, including "Best Price", "Instant Redemption upon Purchase" and other promotional campaigns, which provided customers with a series of special offers on selected quality products as a way to show its appreciation for their support and effectively enhance customer loyalty. The Group also launched a new brand promotion campaign, namely "Best Mart, Always a Friendly Buy", in 2026. By integrating online and offline promotional channels, the Group further strengthened its brand image and enhanced its interaction and connection with customers.
The Group also utilised a variety of outdoor media, such as large-scale advertisements at MTR stations and truck wraps, together with marketing strategies on digital media and social platforms, to further increase its brand exposure and market penetration, thereby attracting more new customers to shop at its stores.
In addition, the Group actively fulfilled its corporate social responsibility by partnering with the charitable foundation under China Merchants Group to launch the "Care 360˚" Neighborhood Support Programme, which aids families in need, continuously promotes community care and inclusion and actively puts into practice the core principles of corporate sustainability.
EMPLOYEES
As at 30 June 2026, the Group employed a total of 1,257 full-time and part-time employees (31 December 2025: 1,227). The increase in the total number of employees was primarily due to the Group's recruitment of additional staff for its newly opened stores. To retain talent and provide its employees with appropriate incentives to enhance their sense of belonging and loyalty, the Group regularly reviews and updates its employee remuneration packages and benefit plans, taking into account labour market supply and remuneration trends as well as individual employee performance. During the Period under Review, the staff costs of the Group (excluding emoluments of the Directors) accounted for approximately 9.6% of its total revenue (six months ended 30 June 2025: approximately 9.7%).
OUTLOOK
Global geopolitical tensions remain high, and uncertainty persists regarding the pace of the external economic recovery. Meanwhile, the active expansion of mainland Chinese e-commerce platforms into Hong Kong has driven the popularity of cross-border online shopping, further intensifying competition in the local retail market. Amid complex and increasingly competitive market conditions, the overall business environment for the retail sector is expected to remain under pressure in the second half of 2026. However, as Hong Kong hosts a series of major international events and exhibitions as well as cultural and sports activities, the number of visitors to Hong Kong and their willingness to spend are steadily recovering. At the same time, consumption of daily necessities has demonstrated strong resilience. Market demand for value-for-money globally sourced food products and healthy snacks continues to grow, presenting the Group with solid development opportunities. Looking ahead, the Group remains cautiously optimistic about its business prospects. To address intense market competition, we are committed to refining operational management, optimizing business processes, and maintaining strict cost controls.
To further strengthen its connection with consumers, the Group officially launched a rebranding campaign in June 2026, adopting "Best Mart, Always a Friendly Buy" as its new core brand value and striving to build a more welcoming, youthful, vibrant and creative brand image. Regarding its store network management, the Group will balance strategic expansion with operational optimization. On one hand, the Group will capitalise on appropriate market opportunities and continue to expand its footprint through a "dual-brand" strategy featuring "Best Mart 360˚" and "FoodVille", aiming to precisely meet the demand for high-quality food across different customer segments. On the other hand, the Group will adhere to strict capital-return discipline by actively negotiating with landlords for more flexible and reasonable lease terms, while regularly reviewing the operational efficiency of existing stores. Through these efforts, the Group aims to comprehensively enhance the overall profitability of its network and deepen its presence in the mass retail market.
Faced with a complex, ever-changing and highly competitive market environment, the Group is comprehensively exploring and researching the application of artificial intelligence in its business processes, aiming to enhance operational efficiency through innovative technology. The Group will further deepen its online-offline integration strategy, fully leverage the advantages provided by the extensive member database of its mobile app and implement targeted marketing through big data analysis to effectively increase member engagement and overall repeat purchase rates.
In terms of online channels, the Group will strengthen its collaboration with the foodpanda mall platform to ensure a seamless shopping experience. The Group will also remain agile in our operational strategies to optimize overall sales performance.
Guided by its core brand philosophy of "Best Quality" and "Best Price", the Group will make every effort to expand its upstream supplier network while ramping up the development of its private label products. These initiatives will solidify our competitive pricing advantage while effectively meeting the market demand for daily necessities. The Board is confident that, through prudent yet flexible strategic planning, strong brand appeal and an optimised product portfolio, the Group will successfully enhance customer loyalty. This will steadily drive the business toward sustainable growth, thus creating long-term and robust returns for shareholders.
Hashtag: #BestMart360
The issuer is solely responsible for the content of this announcement.
About Best Mart 360 Holdings Limited
Best Mart 360 Holdings Limited, mainly operates chain retail stores under the brand "Best Mart 360˚". It offers a wide collection of imported prepackaged leisure foods and other grocery products, principally from overseas. The Group's business objective is to offer "Best Quality" and "Best Price" products to customers through continuous efforts on global procurement with a mission to provide comfortable shopping environment and pleasurable shopping experience to customers. As at 30 June 2026, the Group operates 190 retail stores that are strategically located across 18 districts in Hong Kong and Macau. In addition, the Group's new global gourmet store, "FoodVille", was officially opened in September 2021, which mainly provides globally sourced medium-to-high-end quality food products.
** This press release is distributed by Media OutReach Newswire through automated distribution system, for which the client assumes full responsibility. **
